Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

Benzer Materyaller

• Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin
  Yazar:: Ben Hamida, Azza, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer
  Yazar:: Jacquemier, Jocelyne, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follow-Up Results of the UNICANCER-PACS01 Trial
  Yazar:: Coudert, Bruno, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes
  Yazar:: Bekhouche, Ismahane, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
  Yazar:: Zabouo, Gwladys, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)